HCPLive

Genetic Variations Confer Risk for Multiple Psychiatric Disorders

THURSDAY, Feb. 28 (HealthDay News) -- Specific single nucleotide polymorphisms (SNPs) seem to confer risk of a diverse set of psychiatric disorders, according to a study published online Feb. 28 in The Lancet.

Jordan W. Smoller, MD, from Massachusetts General Hospital, in Boston, and colleagues from the Cross-Disorder Group of the Psychiatric Genomics Consortium examined genome-wide SNP data for autism spectrum disorder, attention-deficit/hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia in 33,332 cases and 27,888 controls of European ancestry. The allelic effects of each disorder were characterized.

In the primary analysis the researchers found that SNPs at four loci (regions on chromosomes 3p21 and 10q24 and within two L-type voltage-gated calcium channel subunits) exceeded the cut-off for genome-wide significance. The effects of these loci were supported for several disorders. Variable diagnostic specificity was seen for loci previously associated with bipolar disorder or schizophrenia. Based on polygenic risk score analysis there were cross-disorder associations, particularly between disorders with adult onset. For all five disorders, pathway analysis supported a role for genes in calcium channel signaling. Enrichment of brain-tissue expression quantitative trait loci was seen in SNPs with evidence of cross-disorder association.

"Our findings show that specific SNPs are associated with a range of psychiatric disorders of childhood onset or adult onset," the authors write. "These results provide evidence relevant to the goal of moving beyond descriptive syndromes in psychiatry, and towards a nosology informed by disease cause."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Most Popular

Recommended Reading

Medical marijuana is legal in Washington state. But the FDA has ordered a Seattle company to stop selling cannabis products for dogs and cats. The products are shipped nationally.
Key steps should be taken to minimize the potential risk of liability resulting from use of telemedicine, according to an article published by the American Medical Association.
An estimated 40% of migraine sufferers also have signs of depression and more than 50% of migraine patients have some form of anxiety disorder. Treating these comorbidities is more art than science, says Mia Minen, MD, Director of Headache Services at NYU Langone Medical Center. In a recent interview she discussed the treatment options ranging from standard drugs like triptans, to Botox, to biofeedback.
Every year, the FBI and its partners in the Internet Crime Complaint Center (IC3) publish a report detailing the number and type of complaints the center receives. These states reported the highest numbers of cyber crimes.
$vAR$